DISCLAIMERThe information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.
email sent successfully
|You are receiving this because you have an account on www.oneGRAVESvoice.com|
|To unsubscribe from these emails, click here|
Trusted Resources: News & Meetings
Latest announcements and gatherings
Early Treatment for Hyperthyroidism Reduces CV Morbidity, Mortality in Graves’ Disease
Regardless of the method used, an early and intensive treatment approach to hyperthyroidism in Graves disease is associated with improvements in cardiovascular morbidity and all-cause mortality, according to study results published in The Lancet Diabetes & Endocrinology.
This retrospective cohort study was designed to assess initial therapy choices for patients with Graves disease by identifying associations between treatment method and long-term cardiovascular morbidity and all-cause mortality. From a cohort of patients diagnosed with hyperthyroidism between January 1998 and December 2013 in South Wales, United Kingdom, patients with Graves disease were identified using a thyroid-stimulating hormone (TSH) receptor antibody test register. Participants’ clinical data were linked to study outcomes using the All-Wales Secure Anonymised Information Linkage Databank. The study had no exclusion criteria, and participants were age- and sex-matched 1:4 to a control population within the same database.
Evidence & EducationRadioiodine Therapy for HyperthyroidismA 37-year-old woman receives a diagnosis...
Evidence & EducationThyroid Disorders and Impairment in Sex LifeThyroid disorders (hypothyroidism, hypot...
Evidence & EducationThyroid Hormone Therapy and InfertilityThyroid hormone plays a major role in bo...
People & PlacesSeattle Children’s Thyroid ProgramSeattle Children’s Thyroid Program is ...
News & MeetingsThyroid Eye Disease Drug Meets Primary Endpoint for Proptosis ReductionTop-line results from the OPTIC trial sh...
People & PlacesElizabeth N. Pearce, MDDr. Elizabeth N. Pearce is Professor of ...
People & PlacesBeth Israel Deaconess Medical Center – Thyroid CenterThe Thyroid Center, the Division of Endo...
send a message
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.